Prudential Financial’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Buy
9,390
+1,020
+12% +$25.5K ﹤0.01% 2210
2026
Q1
$209K Buy
+8,370
New +$236K ﹤0.01% 2128
2025
Q4
Sell
-6,880
Closed -$246K 2389
2025
Q3
$246K Buy
6,880
+65
+1% +$2.97K ﹤0.01% 2162
2025
Q2
$504K Buy
6,815
+3,415
+100% +$193K ﹤0.01% 1937
2025
Q1
$291K Buy
3,400
+320
+10% +$21.8K ﹤0.01% 1995
2024
Q4
$274K Sell
3,080
-74
-2% -$6.32K ﹤0.01% 2008
2024
Q3
$253K Buy
+3,154
New +$224K ﹤0.01% 2448

Other funds holding PRCT

Prudential Financial's PRCT Position: Q2 2026 in Review

Prudential Financial increased its Procept Biorobotics (PRCT) stake by 12% in Q2 2026, buying an estimated $25.5K and bringing the position to 9,390 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #2210.

Prudential Financial first reported a position in PRCT in Q3 2024 and has held it in 7 quarters since. The position peaked at $504K in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Prudential Financial held 9,390 shares of Procept Biorobotics worth $212K as of Q2 2026.
  • Prudential Financial bought 1,020 Procept Biorobotics shares in Q2 2026, an estimated $25.5K.
  • Procept Biorobotics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2210 holding.
  • Prudential Financial first reported a position in Procept Biorobotics in Q3 2024 and has held it in 7 quarters since.
  • Prudential Financial's Procept Biorobotics position peaked at $504K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.